A 954 New Jersey General Assembly · 2020-2021 Regular Session

Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.***

Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2020
Committee Review
Floor Vote
Governor
Introduced Jan 14, 2020 Last action Jun 16, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
5
Key actions
2
Committee
4
Jun 16, 2021
Lower · Passed
Reported out of Assembly Committee with Amendments, 2nd Reading
lower
Mar 17, 2021
Committee
Recommitted to Assembly Appropriations Committee
lower
Feb 24, 2021
Lower · Passed
Reported out of Assembly Committee with Amendments, 2nd Reading
lower
Feb 13, 2020
Committee
Reported out of Senate Committee with Amendments and Referred to Assembly Appropriations Committee
lower
Jan 14, 2020
Introduced
Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
lower
3 primary · 11 co-sponsors

Sponsors